103 related articles for article (PubMed ID: 2022307)
1. Scintigraphic studies in rats. Kinetics of insulin analogues covering wide range of receptor affinities.
Jensen I; Kruse V; Larsen UD
Diabetes; 1991 May; 40(5):628-32. PubMed ID: 2022307
[TBL] [Abstract][Full Text] [Related]
2. Receptor binding and tyrosine kinase activation by insulin analogues with extreme affinities studied in human hepatoma HepG2 cells.
Drejer K; Kruse V; Larsen UD; Hougaard P; Bjørn S; Gammeltoft S
Diabetes; 1991 Nov; 40(11):1488-95. PubMed ID: 1657669
[TBL] [Abstract][Full Text] [Related]
3. Uptake and metabolic fate of [HisA8,HisB4,GluB10,HisB27]insulin in rat liver in vivo.
Authier F; Di Guglielmo GM; Danielsen GM; Bergeron JJ
Biochem J; 1998 Jun; 332 ( Pt 2)(Pt 2):421-30. PubMed ID: 9601071
[TBL] [Abstract][Full Text] [Related]
4. In vivo demonstration of insulin-receptor defect with 123I-labeled insulin and scintigraphic scanning in severe insulin resistance.
Dozio N; Micossi P; Galimberti G; Sartori S; Pozza G; Dosio F; Savi A; Gerundini PG; Fazio F; Chiumello G
Diabetes Care; 1992 May; 15(5):651-6. PubMed ID: 1516485
[TBL] [Abstract][Full Text] [Related]
5. Scintigraphic distribution of 123 I labelled proinsulin, split conversion intermediates and insulin in rats.
Sodoyez-Goffaux F; Sodoyez JC; Koch M; De Vos CJ; Frank BH
Diabetologia; 1988 Nov; 31(11):848-54. PubMed ID: 3234639
[TBL] [Abstract][Full Text] [Related]
6. In vivo imaging and quantitative analysis of insulin-receptor interaction in lean and obese Zucker rats.
Sodoyez JC; Sodoyez-Goffaux F; Treves S; Kahn CR; von Frenckell R
Diabetologia; 1984 Mar; 26(3):229-33. PubMed ID: 6370772
[TBL] [Abstract][Full Text] [Related]
7. Subcutaneous insulin absorption explained by insulin's physicochemical properties. Evidence from absorption studies of soluble human insulin and insulin analogues in humans.
Kang S; Brange J; Burch A; Vølund A; Owens DR
Diabetes Care; 1991 Nov; 14(11):942-8. PubMed ID: 1797506
[TBL] [Abstract][Full Text] [Related]
8. Dynamic 131I-labelled insulin distribution in rabbits as seen by in-vivo scintigraphic studies.
Bourgeois P; Frühling J; Langohr M; Coel J; Verbist A; Ghanem G; Legros F
J Endocrinol; 1983 Sep; 98(3):331-42. PubMed ID: 6352847
[TBL] [Abstract][Full Text] [Related]
9. Receptor-isoform-selective insulin analogues give tissue-preferential effects.
Vienberg SG; Bouman SD; Sørensen H; Stidsen CE; Kjeldsen T; Glendorf T; Sørensen AR; Olsen GS; Andersen B; Nishimura E
Biochem J; 2011 Dec; 440(3):301-8. PubMed ID: 21851336
[TBL] [Abstract][Full Text] [Related]
10. Differing effects of antiinsulin serum and antiinsulin receptor serum on 123I-insulin metabolism in rats.
Sodoyez JC; Sodoyez Goffaux F; von Frenckell R; De Vos CJ; Treves S; Kahn CR
J Clin Invest; 1985 May; 75(5):1455-62. PubMed ID: 3889055
[TBL] [Abstract][Full Text] [Related]
11. Altered insulin distribution and metabolism in type I diabetics assessed by [123I]insulin scanning.
Hachiya HL; Treves ST; Kahn CR; Sodoyez JC; Sodoyez-Goffaux F
J Clin Endocrinol Metab; 1987 Apr; 64(4):801-8. PubMed ID: 3546355
[TBL] [Abstract][Full Text] [Related]
12. In vivo imaging of insulin receptors by PET: preclinical evaluation of iodine-125 and iodine-124 labelled human insulin.
Iozzo P; Osman S; Glaser M; Knickmeier M; Ferrannini E; Pike VW; Camici PG; Law MP
Nucl Med Biol; 2002 Jan; 29(1):73-82. PubMed ID: 11786278
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the receptor binding properties of monoiodoinsulin isomers and the identification of different insulin receptor specificities in hepatic and extrahepatic tissues.
Podlecki DA; Frank BH; Kao M; Horikoshi H; Freidenberg G; Marshall S; Ciaraldi T; Olefsky JM
Diabetes; 1983 Aug; 32(8):697-704. PubMed ID: 6347766
[No Abstract] [Full Text] [Related]
14. Novel hepatoselective insulin analogues: studies with covalently linked thyroxyl-insulin complexes.
Shojaee-Moradie F; Eckey H; Jackson NC; Schüttler A; Brandenburg D; Sönksen PH; Jones RH
Diabet Med; 1998 Nov; 15(11):928-36. PubMed ID: 9827847
[TBL] [Abstract][Full Text] [Related]
15. Equivalent in vivo biological activity of insulin analogues and human insulin despite different in vitro potencies.
Ribel U; Hougaard P; Drejer K; Sørensen AR
Diabetes; 1990 Sep; 39(9):1033-9. PubMed ID: 2200728
[TBL] [Abstract][Full Text] [Related]
16. In vivo imaging of insulin receptors in monkeys using 18F-labeled insulin and positron emission tomography.
Eastman RC; Carson RE; Jacobson KA; Shai Y; Channing MA; Dunn BB; Bacher JD; Baas E; Jones E; Kirk KL
Diabetes; 1992 Jul; 41(7):855-60. PubMed ID: 1612200
[TBL] [Abstract][Full Text] [Related]
17. Absorption kinetics and action profiles of subcutaneously administered insulin analogues (AspB9GluB27, AspB10, AspB28) in healthy subjects.
Kang S; Brange J; Burch A; Vølund A; Owens DR
Diabetes Care; 1991 Nov; 14(11):1057-65. PubMed ID: 1797487
[TBL] [Abstract][Full Text] [Related]
18. Distribution of 125I-labelled insulin-binding sites in peripheral tissues of the normal and diabetic rat: an autoradiographic study.
Thompson CS; Sykes RM; Muddle J; Dashwood MR
J Endocrinol; 1991 Jan; 128(1):85-9. PubMed ID: 1999679
[TBL] [Abstract][Full Text] [Related]
19. Soluble, fatty acid acylated insulins bind to albumin and show protracted action in pigs.
Markussen J; Havelund S; Kurtzhals P; Andersen AS; Halstrøm J; Hasselager E; Larsen UD; Ribel U; Schäffer L; Vad K; Jonassen I
Diabetologia; 1996 Mar; 39(3):281-8. PubMed ID: 8721773
[TBL] [Abstract][Full Text] [Related]
20. Shortened insulin analogues: marked changes in biological activity resulting from replacement of TyrB26 and N-methylation of peptide bonds in the C-terminus of the B-chain.
Záková L; Barth T; Jirácek J; Barthová J; Zórad S
Biochemistry; 2004 Mar; 43(8):2323-31. PubMed ID: 14979729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
